Arthritis is a condition that causes joint inflammation, leading to pain, swelling, and stiffness. It affects hundreds of millions of people worldwide. About 1 in 5 adults globally are suffering with arthritis, and the condition can reduce quality of life by limiting mobility, causing prolonged discomfort, and making routine activities like walking, writing, or playing harder. Although it is often linked with older adults, arthritis also affects children. It is estimated that 1 in 1,000 children are diagnosed with juvenile arthritis. In children, it can impact movement, school life, interfere with growth, and overall well-being.
Most people think arthritis only causes joint pain. When a child has swollen knees or stiff fingers, the problem seems limited to those joints. However, research shows that arthritis in children can also affect the eyes. This connection can be serious because it often develops without clear symptoms.
Juvenile idiopathic arthritis, or JIA, is the most common type of arthritis in children. Doctors diagnose it when joint inflammation lasts more than six weeks before the age of sixteen and no clear cause is found. JIA is known for joint pain and swelling, but it can also affect other parts of the body, including the eyes.
The Silent Risk of Uveitis in Kids
Children with JIA may develop uveitis, which is inflammation inside the eye. Studies show that 10 percent to 30 percent of children with JIA develop this condition. In many cases, it begins without pain or visible symptoms. Because early symptoms are often absent, the inflammation may continue without detection. Over time, this can lead to complications such as cataracts or glaucoma. Some children experience partial vision loss. By the age of eighteen, up to 30 percent of patients with JIA-associated uveitis lose vision in at least one eye. Regular eye examinations are necessary for children with JIA. Even when no symptoms are present, doctors need to monitor eye health to detect changes early.
What Scientists Discovered about the Immune System
Earlier research focused on T-cells as the main cause of uveitis. T-cells are part of the immune system and help fight infections. In some cases, they attack healthy tissue. Recent studies show that B-cells are also involved. B-cells usually produce antibodies, but in children with JIA and uveitis, certain B-cell types appear in higher numbers.
In a study of 158 children with JIA, including 44 with uveitis, researchers found increased levels of specific B-cells in those with eye inflammation. These cells showed signs of activation and movement toward inflamed areas. B-cells were also found in eye tissue samples collected during surgery. This confirms their presence at the site of inflammation.
How B-cells and T-cells Work Together
Research indicates that B-cells and T-cells interact during the disease process. This interaction contributes to inflammation in the eye, particularly when these immune cells migrate into ocular tissues and become abnormally activated. Experimental studies tested what happens when communication between these cells is blocked. When this interaction was reduced, the severity of eye inflammation also decreased. These findings suggest that both cell types are involved in the disease mechanism and that their interaction plays a role in how uveitis develops.
What this Means for Future Treatment
Current treatment for JIA-associated uveitis starts with steroid eye drops. If needed, doctors use medications that target inflammatory pathways. More than 25 percent of patients do not respond well to these treatments. The role of B-cells suggests additional treatment options. Drugs that target B-cells or block their interaction with T-cells are being studied in other autoimmune diseases, including multiple sclerosis and lupus. Further research is required before these treatments can be used widely in children. Safety and effectiveness must be confirmed through clinical studies.
Why Early Detection Matters
Researchers are also studying whether B-cells can be used as markers to detect uveitis early. Blood tests that identify these cells may help determine which children are at higher risk. At present, regular eye screening remains the standard method for detecting uveitis. Improved markers may allow earlier diagnosis and treatment in the future.
A New Way to Understand Childhood Arthritis
Current evidence shows that arthritis in children is not limited to joint inflammation. It can involve multiple systems, including the eyes. The identification of B-cells and their interaction with T-cells provides a clearer explanation of how uveitis develops. This information may support the development of more targeted treatments. Ongoing research is needed to confirm these findings and apply them in clinical care.
FAQs on Arthritis Cause Eye Problems
Q: Can arthritis in children affect the eyes without symptoms?
A: Yes, arthritis in children can affect the eyes without obvious symptoms. Conditions like uveitis often develop silently, especially in early stages, which is why regular eye checkups are important for early detection.
Q: What is uveitis in children with juvenile arthritis?
A: Uveitis is inflammation inside the eye that can occur in children with juvenile idiopathic arthritis. It mainly affects the front part of the eye and can lead to complications like vision loss if not treated early.
Q: Why do some children with arthritis develop eye inflammation?
A: Not all children with arthritis develop eye inflammation, and the exact reason is still being studied. Research suggests that certain immune responses, including the interaction of B-cells and T-cells, may increase the risk in some children.
Q: How do B-cells and T-cells cause eye problems in arthritis?
A: B-cells and T-cells are part of the immune system and normally protect the body. In some cases, they become overactive and target the body’s own tissues, including the eye, leading to inflammation such as uveitis.
Q: What are the early signs of uveitis in children?
A: Uveitis in children often has no early symptoms, which makes it difficult to detect. In later stages, signs may include blurred vision, eye redness, or sensitivity to light, but regular screening is the most reliable way to catch it early.
Q: How common is eye inflammation in children with juvenile idiopathic arthritis?
A: Studies show that about 10 percent to 30 percent of children with juvenile idiopathic arthritis develop uveitis. This makes it a known but not universal complication of the disease.
Q: What happens if uveitis in children is not treated?
A: If left untreated, uveitis can lead to serious eye problems such as cataracts, glaucoma, and even permanent vision loss. Early diagnosis and treatment are important to prevent long-term damage.
Q: What treatments are available for uveitis in children with arthritis?
A: Treatment usually starts with steroid eye drops to reduce inflammation. If needed, doctors may use medications or biologic drugs, although some children may not respond to all treatments.
Q: Can blocking immune cell interaction reduce eye inflammation in arthritis?
A: Experimental studies suggest that reducing interaction between B cells and T cells can lower inflammation. While this approach shows promise, it is still being researched and is not yet a standard treatment.
Q: Who is at higher risk of developing uveitis with juvenile arthritis?
A: Children who develop arthritis at a younger age, especially girls and those with certain immune markers, may have a higher risk. However, these factors do not fully predict who will develop eye inflammation.
External Sources
- Jebson BR, Ingledow B, Alexiou V, Kubiak J, Jenkins P, Meng Y, Kartawinata M, Restuadi R, Lin WY, Wallace C, Chu CJ. Altered B cell activation contributes to the immunopathogenesis of childhood arthritis-associated uveitis. Nature Communications. 2026 Feb 3;17(1):714. Doi: 10.1038/s41467-025-68264-5.
- Smith JR, Stempel AJ, Bharadwaj A, Appukuttan B. Involvement of B cells in non‐infectious uveitis. Clinical & translational immunology. 2016 Feb;5(2):e63. Doi: 10.1038/cti.2016.2.
- Zhu L, Chen B, Su W. A review of the various roles and participation levels of B-cells in non-infectious uveitis. Frontiers in immunology. 2021 May 14;12:676046. Doi: 10.3389/fimmu.2021.676046.
Disclaimer:
Some aspects of the webpage preparation workflow may be informed or enhanced through the use of artificial intelligence technologies. While every effort is made to ensure accuracy and clarity, readers are encouraged to consult primary sources for verification. External links are provided for convenience, and Honores does not endorse, control, or assume responsibility for their content or for any outcomes resulting from their use. The author declares no conflicts of interest in relation to the external links included. Neither the author nor the website has received any financial support, sponsorship, or external funding. This content is for informational purposes only and is not medical advice. Please consult a qualified physician before making health decisions. Images are for representational purposes only. Photo by Gustavo Fring.